VIRET JEAN-FREDERIC (Chief Financial Officer) reported 1 transaction at NGM BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 4/8/2024ACC: 0000950170-24-042611
Officer· Chief Financial Officer
Since Nov 2023
-453.04K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
453.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.04K
Price / share
—
Trade value
—
% of position
New position
4/5/2024
3.04K→0.00
Total
Net shares
−3.04K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/5/2024 | U · U | −3.04K | — | — | New position | 3.04K | 0.00 |
| Total | −3.04K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
450K shares
Shares
−450K
Strike price
0.77
Held after
0.00
Exercisable
—
4/5/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock450K shares | 4/5/2024 | D · Disposition | −450K | 0.77 | — | 0.00 |